According to the result of this study right here that you can see up on your screen,

researchers for the first time have found a treatment that completely removed the

rectal cancer in every patient that participated in the trial, meaning that every single patient in the study is in the

is in remission with no chemo, no radiation,

and no surgery.

And even though the study was small,

the results, they're not only heartening, but also, according to the lead

researcher in the study, they open up a potential new corridor at fighting cancer, which

they will be quickly expanding to things like stomach, pancreatic, as well as bladder cancer.

Furthermore, the therapy that they're testing, which is monoclonal antibodies,

they have none of the toxic side effects of other popular cancer treatments, especially the ones that are

currently being used at scale.

And so with all these positive elements lining up here one after the other, let's go through

the details of the study together.

To start with, this paper, it was published in the New England Journal of Medicine and it's

titled PD1 blockade in mismatch repair deficient locally advanced rectal cancer.

This study was led by researchers over at the Memorial Sloan Kettering

Center here in New York and they were testing the viability of monoclonal

antibodies as a treatment for people suffering from advanced forms of rectal cancer.

Specifically, in this study group, the researchers had 12 patients

with the median age being 54 and with 62% of them being women.

And these patients were all suffering from advanced rectal cancer,

...